Related Experiment Video
Updated: Aug 18, 2026

Testing the Role of Multicopy Plasmids in the Evolution of Antibiotic Resistance
Published on: May 2, 2018
Gram-negative bacterial resistance to cephalosporins in community-acquired infections in Turkey
1Gulhane Military Hospital, Department of Infectious Diseases and Clinical Microbiology, Ankara, Turkey. hakanerdem1969@yahoo.com
Abstract:
Cephalosporins are widely used and trustworthy antibiotics in daily medical practice. Although antibacterial resistance has been reported in hospital wards, there are less data for community-acquired infections. In this study we investigated the cephalosporin susceptibility profiles of community-acquired Gram-negative bacteria isolates in Sivas Kizilay Medical Center (Turkey) between March 2002 and March 2003. In our study, 949 Escherichia coli, 165 Proteus spp., 97 Enterobacter spp., 24 Klebsiella spp and 84 Pseudomonas aeruginosa strains were evaluated. Cefepime seemed to be the most effective antibiotic against our community-acquired Gram-negative isolates. Resistance to this drug was 19.3% for P. aeruginosa and around 0-10.6% for enteric bacteria. Enteric pathogen resistance ranged between 44.3-100% for cefazolin, 25-51.9% for cefuroxime, 4.8-25.3% for ceftriaxone, 5.4-14.5% for ceftazidime. Resistance in enteric pathogens to gentamicin ranged between 5.8-15.4%, to amikacin between 3.8-6.25%, to ciprofloxacin between 6.7-20%. 8.1% of P. aeruginosa were resistant to ciprofloxacin. With these profiles the aminoglycosides and ciprofloxacin resemble highly effective cephalosporins like cefepime. On the contrary, first- and second-generation cephalosporins, trimethoprim-sulfamethoxazole, ampicillin and ampicillin-sulbactam are no longer used in probable Gram-negative bacterial infections in our region. Since treatment based on cephalosporins was less efficacious than expected in community-acquired infections, urgent measures are needed to limit antibacterial resistance outside of hospitals.
Insights
Community-acquired Gram-negative bacteria show concerning cephalosporin resistance. Cefepime remains effective, unlike older cephalosporins, highlighting the need for urgent resistance control measures.
Area of Science:
- Microbiology
- Infectious Diseases
- Pharmacology
Background:
- Cephalosporins are essential antibiotics, but resistance in community settings is under-researched.
- Rising antibacterial resistance necessitates understanding local susceptibility patterns.
Purpose of the Study:
- To determine cephalosporin susceptibility profiles of community-acquired Gram-negative bacteria in Sivas, Turkey.
- To evaluate the efficacy of various antibiotics against common Gram-negative pathogens.
Main Methods:
- Analysis of 949 Escherichia coli, 165 Proteus spp., 97 Enterobacter spp., 24 Klebsiella spp., and 84 Pseudomonas aeruginosa isolates.
- Antimicrobial susceptibility testing for cephalosporins and other agents.
Main Results:
- Cefepime demonstrated the highest efficacy against Gram-negative isolates (19.3% resistance in P. aeruginosa, 0-10.6% in enteric bacteria).
- High resistance rates were observed for older cephalosporins (cefazolin: 44.3-100%), while aminoglycosides and ciprofloxacin showed comparable effectiveness to cefepime.
- First- and second-generation cephalosporins, trimethoprim-sulfamethoxazole, ampicillin, and ampicillin-sulbactam were largely ineffective.
Conclusions:
- Cephalosporin efficacy in community-acquired infections is declining, necessitating urgent interventions.
- Aminoglycosides and ciprofloxacin represent viable alternatives to less effective cephalosporins.
- Antibacterial resistance surveillance and stewardship are crucial outside hospital settings.
Related Concept Videos
Development of Antibiotic Resistance
Mechanism of Antibiotic Resistance in MRSA
Clinical Significance of Antibiotic Resistance
Inhibitors of Gram-positive Cell Wall Synthesis
Urine Studies II: Urine Culture and Sensitivity Test
Inhibitors of Bacterial DNA Synthesis